Member Info for Badsterman

Well Porky,

Credit to you for forecasting Valirx accurately, I humbly take back my critique of your obsession with the "cash runway".

I'm fully anticipating a mid afternoon RNS with all resolutions passed, along with a fatuous statement from Cox about a "transformational 2024".

What's your prediction for the next cash call? November 2024?

This statement was issued following the last fundraise;

"ValiRx Chairman, Kevin Cox commented: "We would like to thank shareholders for showing their support of our strategy to develop the tCRO through the approval of resolutions 1 to 3. We look forward to updating the market on progress in the near future."

All we've had is a grandiose RNS about an "invoice" - no facts or figures, partners, running costs or contract values.

Now they've come cap in hand wanting £400,000 for the "commercial and brand development" of Inaphaea!!

The arrogance of Dr Cox beggars belief.

Today the "full of confidence and unconcerned" pick up their wages and press ahead with yet another fund raise, despite having no meaningful progress to offer shareholders.

I've lost interest in webinars, Q&A's and updates - it's just propaganda.

Sadly, Porky was right. 🙄

Come on TRX, give me an exit strategy.

Calling £1 by end of next month - fast forward to 10:13.

https://youtu.be/ShgK5Q1rKNI

It's a stock chart analysis; take it, or leave it.

Bell up

Lucy up

Reebok deal online soon

Microsalt IPO

60,000lb salt order with a tier one food company.

Spread tightening, 7p to buy.

Hope springs eternal...🤣

Gross, Cohen and Dabrowski exercising stock options;

https://www.nasdaq.com/market-activity/stocks/lucy/sec-filings

Here you go Top;

http://tinyurl.com/ycyx5f93

As I understand it: you have to be above 1 dollar, for a period of 30 days, to maintain your listing.

But,

LUCY have 180 days from the 4th August to regain NASDAQ compliance, Q1 sales data will be too late.

They'd have to apply for an extension to a Hearings Panel (by submitting a plan of compliance) with no guarantees of acceptance.

Delisting would be a disaster, maybe a trade sale at a knockdown price.

Can't see a Lucy rerate Sea, not without my Smartglasses on! 🤪

They'll be banking on Nautica and Reebok to deliver some sales before they get delisted.

Either that or they've another deal in the pipeline, to prop up the SP.

Cash in the bank is all that's holding the LUCY SP @45 cents.

Oh...and last week; Suzy mixing it with Caroline Austin of AZ (VP, Head of Transactions and Business Development)

http://tinyurl.com/mv9hk5n5

EUDA up 5.98%

EUDAW (W = warrants) up 128.74%

EUDA short interest has declined 67% since last month.

https://www.marketbeat.com/stocks/NASDAQ/EUDAW/sec-filings/

All the market signals are positive. 🤪

Reputation?

This new Board has a good reputation in the industry.

Why do you think that professionals from Kings, Barcelona, Hokkaido, Ambrose, TRX, Stingray and Professor Hargreaves are working with Valirx?

Your post insults their intelligence and your own, in equal measure.

Bleak?

Two billion dollar deals today, in the biotech sector, (Icosavax and Systimmune).

Yet Valirx drops, despite it's carefully managed finances, innovative pipeline of evaluations, P2 assets and a fully functioning laboratory.

The poor reputation of the previous BOD is proving hard to shake off.

Well, fellow Tek investors,

My Amazon Microsalt order should arrive this week.

At the behest of my wife, we use Lo-Salt. It has 66% less sodium, but contains 23% Potassium Chloride, Sodium Chloride, Anti-caking agents (Magnesium Carbonate and Sodium Hexacyanoferrate).

I'll run a taste test with the wife's help and let you know!. 🤪

Porks; I'm bemused as to why your posts are being removed.

Ambrose are a startup with limited funding; that information is in the public domain.

I disagree with your opinions about Valirx (e.g. in my view your obsession with the "cash runway" borders on insanity), but surely you've the right to pass comment on the latest RNS?

LSE - what's happened to freedom of speech?

You guys need to get real, Ambrose are a biotech startup having raised £500,000 (as of April).

The do have a very experienced board:

https://ambrosehc.com/team/

Also plans to IPO in thr Middle East at some point;

https://www.agbi.com/articles/uk-pharma-startup-targets-gulf-for-future-ipo/

It good news, but it won't be blowing the doors off just yet.

Perhaps Flagstaff could explain the £215,000, instead of getting paid for yet another "News Story irrelevant to Microsalt" post.

🙄

Https://tinyurl.com/nztxyuk3

"Oxygen supplementation is one way to help patients who cannot breathe adequately on their own"

Anyone know of a company manufacturing portable oxygen concentrators in China?

🤔

Https://tinyurl.com/2jxpwhut

Although, the piece states "The shares issued for the acquisition may hold back the share price in the short-term and there could be an even better buying opportunity."

Well Lolly, despite the abuse thrown in your direction you've been proven correct about the SP.

Whatever delightful narrative Agricore posts about the aesthetically pleasing glasses, the bottom line is sales are down for the comparable nine months ending 2023 (536,725) vs 2022 (592,720)

The accounts prove Harrison Gross is brilliant at spending dollars on product development, but he can't deliver sales. As has already been posted, a change is needed.  

Let's see how the US market reacts this afternoon.....